Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-03-13

FDA Approved: SOHONOS — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SOHONOS (palovarotene) by Ipsen Biopharmaceuticals, Inc., resulting in updated labeling that expands the product's i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOHONOS (PALOVAROTENE)

Snippet

SUPPL AP for SOHONOS (PALOVAROTENE)